Tricky LBO model test: Comps and PPE

Hello Monkeys,

Two questions regarding a model test that i received.

1.) If there are comps given with median/ avg. gross margin and EBITDA margin, how would you model this into your income statement? My way: put those figures in last year and then gradually model towards this figure. Also, use EV/EBITDA from comps for entry and exit

2.) PPE: Currently, the value of PPE is given as "value of PP&E from 3rd party estimate"; if i try to backsolve those figures with last year ppe + capex - depreciation, does not solve. How should I model this going forward, given the transaction is an asset deal? I modelled Capex % of revenue, depreciation with a capex schedule.

Thanks!!

 
Most Helpful
Prospect in IB-M&A:

1.) If there are comps given with median/ avg. gross margin and EBITDA margin, how would you model this into your income statement? My way: put those figures in last year and then gradually model towards this figure. Also, use EV/EBITDA from comps for entry and exit

I’m not a modeling expert, but seems that you can basically just use those stats as your IS if you don’t have other info. You just need to find the cash flows.
Prospect in IB-M&A:

2.) PPE: Currently, the value of PPE is given as "value of PP&E from 3rd party estimate"; if i try to backsolve those figures with last year ppe + capex - depreciation, does not solve. How should I model this going forward, given the transaction is an asset deal? I modelled Capex % of revenue, depreciation with a capex schedule.

Here it sounds like they’re giving you something for a market value as opposed to book. That’s likely going to be what is actually paid, which should be your Gross PP&E basis for moving forward.

 
  1. sounds plausible. If you have higher margins, you might actually have a company that is a winner in the sector (operational excellence, brand, etc). It's a reason to further analyse drivers behind this.

  2. PPE from 3rd party is indeed the value you took from transaction date (and increase depreciation based on that). Remainder is goodwill. Seller will record a capital gain from the sale of the assets (value in excess of book value).

 

Seems like you're having more issues with question 2 than the first one.

Appears to me the prompt is telling you the market value of PPE compared to your book value of PPE you have in your balance sheet. Assume this third party valuation is higher than what you have in the book, then what you need to do is adjust this amount as part of the excess purchase consideration (i.e. excess purchase price consideration to be split between goodwill and revaluation of PPE).

Following which you would need to create a new line item for deferred tax liabilities created (due to fair value adjustment providing a future benefit) and this would correspondingly increase your goodwill. Note that when this happens your net assets stay the same - increase in goodwill from DTL and the DTL itself.

Finally you can depreciate the revalued PPE as per what is given in your prompt or whatever you think is reasonable. New buildings? 20 years. New trucks? 8 years. Anything reasonable should work, you get the drift.

 

Id voluptatibus sed quaerat. Similique aut aut reprehenderit ut ratione corporis voluptatibus.

Autem earum voluptas laboriosam ex iste ut. Voluptatem doloribus rerum temporibus magni. Culpa quo beatae iste veritatis tempore rem.

Tenetur tempora repellat aut adipisci qui qui consequuntur. Qui molestias consequuntur quis. Unde illo et magnam voluptatem qui omnis.

Nihil qui unde et voluptate fugit dolorem quia. Soluta ipsum fugit qui. Voluptate voluptas veritatis voluptatem ducimus natus. Tempore voluptatibus itaque fuga sint eaque dolores et.

Career Advancement Opportunities

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 99.0%
  • Warburg Pincus 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

May 2024 Private Equity

  • Principal (9) $653
  • Director/MD (22) $569
  • Vice President (92) $362
  • 3rd+ Year Associate (91) $281
  • 2nd Year Associate (206) $268
  • 1st Year Associate (388) $229
  • 3rd+ Year Analyst (29) $154
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (315) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”